Cost effectiveness of hepatitis C treatments: Need for a comprehensive evaluation

Zachary DeNardo; Minha Choi; Michelle Stiller; Dillon Buechel

首页> 外文期刊>Kaohsiung Journal of Medical Sciences >Cost effectiveness of hepatitis C treatments: Need for a comprehensive evaluation

【24h】

Cost effectiveness of hepatitis C treatments: Need for a comprehensive evaluation

机译：丙型肝炎治疗的成本效益：需要进行全面评估

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

The article by Tsai, et al. provides a real-world cost-effectiveness framework for pegylated interferon (PEG-IFN) plus ribavirin (RBV) combination therapy using a retrospective national health data [1]. What makes this article interesting is that while in the United States and Europe there is an increased uptake of the new directly acting antiviral agents (DAA) in the treatment of hepatitis C (HCV); in Taiwan, the older treatments are still being evaluated for their cost effectiveness profile.

机译：蔡等人的文章。使用回顾性的国家卫生数据，为聚乙二醇化干扰素（PEG-IFN）加利巴韦林（RBV）联合治疗提供了现实世界的成本效益框架[1]。使这篇文章有趣的是，尽管在美国和欧洲，丙型肝炎（HCV）的治疗中新的直接作用抗病毒药物（DAA）的吸收有所增加。在台湾，较旧的治疗方法仍在评估其成本效果。

著录项

来源
《Kaohsiung Journal of Medical Sciences》 |2017年第11期|共2页
作者
Zachary DeNardo; Minha Choi; Michelle Stiller; Dillon Buechel;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类医药、卫生;
关键词

相似文献

外文文献
中文文献
专利

1. The clinical effectiveness and cost-effectiveness of peginterferon alfa and ribavirin for the treatment of chronic hepatitis C in children and young people: a systematic review and economic evaluation [J] . Health technology assessment: HTA . 2014,第65期

机译：聚乙二醇干扰素α和利巴韦林治疗儿童和年轻人慢性丙型肝炎的临床疗效和成本效益：系统评价和经济评价
2. Who to screen for hepatitis C? A cost-effectiveness study in Belgium of comprehensive hepatitis C screening in four target groups [J] . L. Opstaele, R. Bielen, S. Bourgeois, Acta gastro-enterologica Belgica . 2019,第3期

机译：谁筛选丙型肝炎？在四个目标群体中综合丙型肝炎筛选的比利时成本效益研究
3. Evaluation of cost-effectiveness of peginterferon plus ribavirin for chronic hepatitis C treatment and direct-acting antiviral agents among HIV-infected patients in the prison and community settings [J] . Chen Cheng-Pin, Cheng Chien-Yu, Zou Huachun, Journal of microbiology, immunology, and infection: Wei mian yu gan ran za zhi . 2019,第4期

机译：评价PEGINTERFEREN PRIBAVIRIN在监狱和社区环境中艾滋病毒感染患者慢性丙基肝炎治疗和直接作用抗病毒剂的评价
4. The influence of the choice of the cost index on the effectiveness of optimal resources allocation strategies for Hepatitis B Virus treatment [C] . Paolo Di Giamberardino, Flavia Forconi, Daniela Iacoviello, European Control Conference . 2019

机译：费用指数选择对乙肝病毒治疗最佳资源分配策略有效性的影响
5. Economic evaluation of vaccination programs: Cost-effectiveness, externalities, and affordability of hepatitis B vaccination. [D] . Kim, Sun-Young. 2006

机译：疫苗接种计划的经济评估：乙肝疫苗接种的成本效益，外部性和负担能力。
6. The clinical effectiveness and cost-effectiveness of peginterferon alfa and ribavirin for the treatment of chronic hepatitis C in children and young people: a systematic review and economic evaluation. [O] . Debbie Hartwell, Keith Cooper, Geoff K Frampton, -1

机译：聚乙二醇干扰素α和利巴韦林在儿童和年轻人中治疗慢性丙型肝炎的临床疗效和成本效益：系统评价和经济评价。
7. Cost effectiveness of hepatitis C treatments: Need for a comprehensive evaluation [O] . Zachary DeNardo, Minha Choi, Michelle Stiller, 2017

机译：丙型肝炎治疗的成本效益：需要进行全面评估

Cost effectiveness of hepatitis C treatments: Need for a comprehensive evaluation

摘要

著录项

相似文献

相关主题

期刊订阅